Grafa News and Videos — Page 692

Thor Industries (NYSE:THO) reported a drop in fiscal third-quarter profit and revenue, prompting the recreational vehicle manufacturer to lower its full-year earnings expectations.

MannKind (NASDAQ:MNKD) achieved key clinical development milestones for its investigational lung disease therapy, pushing its dry powder formulation of nintedanib further into mid-stage clinical testing.

KBR (NYSE:KBR) announced that its Mission Technology Solutions unit has been awarded a landmark $8 billion ceiling contract by the U.S. National Science Foundation (NSF) to provide comprehensive science and engineering support for the U.S. Antarctic Program.

T1 Energy (NYSE:TE) has entered into a definitive agreement to acquire KORE Power for an aggregate enterprise value of approximately $32 million, securing a specialized foothold in the rapidly expanding utility-scale energy storage sector.

IDEAYA Biosciences (NASDAQ:IDYA) has entered into a clinical collaboration agreement with Swiss healthcare giant Roche to evaluate a novel combination therapy aimed at a genetically distinct and difficult-to-treat form of pancreatic cancer.

Apple (NASDAQ:AAPL) has agreed to supply local financial data to India's antitrust regulator, dropping its long-standing refusal to do so as part of a high-stakes probe into its mobile app marketplace dominance.

XRP Ledger marked its 14th anniversary on 3 June 2026 as Ripple leaders pointed investors back to the network’s original purpose.

Victoria’s Secret shares jumped about 50% in a single session - the best day in the company’s history - after earnings showed sales up 15%, profit nearly quadrupled and earnings per share roughly double Wall Street expectations.

Zhihu (NYSE:ZH) reported a sharp increase in adjusted profitability for the first quarter of 2026, overcoming a contraction in top-line revenue through disciplined operational efficiency and reduced overhead.

DBV Technologies (NASDAQ:DBVT) has screened the first participant in its THRIVE study, evaluating the Viaskin Peanut patch in infants aged 6 to 12 months over a multi-year period.